Evidence map›Paper›PMID 40004040›Full record

ArticleInternational journal of molecular sciences2025

Generation and Characterization of Human iPSC-Derived Astrocytes with Potential for Modeling X-Linked Adrenoleukodystrophy Phenotypes.

Navtej Kaur, Jaspreet Singh

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. CRISPR-edited iPSCs reveal BSN gene mutations induce neuronal hyperexcitability via astrocyte lipid accumulation.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Navtej KaurDepartment of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA.
Jaspreet SinghDepartment of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA.ORCID 0000-0002-6563-5424

Funding

Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophyR01NS114245 · NINDS · HENRY FORD HEALTH SYSTEM · PI SINGH, JASPREET · 2021 to 2024
$1.4M
Deciphering neuroinflammation-specific regulatory RNA and metabolic networks in human iPSC-derived astrocytes in cerebral adrenoleukodystrophyR21NS114775 · NINDS · HENRY FORD HEALTH SYSTEM · PI SINGH, JASPREET · 2020 to 2020
$414k
Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophyR56NS114245 · NINDS · HENRY FORD HEALTH SYSTEM · PI SINGH, JASPREET · 2020 to 2020
$376k
Funds from Henry Ford Hospital A10263 and A30973NIH HHS 1R01NS114775-04A1NIH HHS R21NS114245NINDS NIH HHS R01 NS114245NINDS NIH HHS R21 NS114775NINDS NIH HHS R56 NS114245
6 · The paper itself

Abstract

X-adrenoleukodystrophy (X-ALD) is a peroxisomal metabolic disorder caused by mutations in the ABCD1 gene encoding the peroxisomal ABC transporter adrenoleukodystrophy protein (ALDP). Similar mutations in ABCD1 may result in a spectrum of phenotypes in males with slow progressing adrenomyeloneuropathy (AMN) and fatal cerebral adrenoleukodystrophy (cALD) dominating most cases. Mouse models of X-ALD do not capture the phenotype differences and an appropriate model to investigate the mechanism of disease onset and progress remains a critical need. Here, we generated induced pluripotent stem cell (iPSC) lines from skin fibroblasts of two each of apparently healthy control, AMN, and cALD patients with non-integrating mRNA-based reprogramming. iPSC lines expanded normally and expressed pluripotency markers Oct4, SOX2, NANOG, SSEA, and TRA-1-60. Expression of markers SOX17, Brachyury, Desmin, OXT2, and beta tubulin III demonstrated the ability of the iPSCs to differentiate into all three germ layers. iPSC-derived lines from CTL, AMN, and cALD male patients were differentiated into astrocytes. Differentiated AMN and cALD astrocytes lacked ABCD1 expression and accumulated saturated very long chain fatty acids (VLCFAs), a hallmark of X-ALD, and demonstrated differential mitochondrial bioenergetics, cytokine gene expression, and differences in STAT3 and AMPK signaling between AMN and cALD astrocytes. These patient astrocytes provide disease-relevant tools to investigate the mechanism of differential neuroinflammatory response in X-ALD and will be valuable cell models for testing new therapeutics.

Indexed as

AdrenoleukodystrophyAstrocytesInduced Pluripotent Stem CellsATP Binding Cassette Transporter, Subfamily D, Member 1Cell DifferentiationFibroblastsHumansMalePhenotypeABCD1 protein, humanATP Binding Cassette Transporter, Subfamily D, Member 1ABCD1astrocytescytokinesinduced pluripotent stem cellsmitochondriaX-ALD

Identifiers

PMID40004040
PMCPMC11855073

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.